Company Financials

Travere Therapeutics Inc. Financials

United States dollar

business Travere Therapeutics Inc. Company Profile

Main Stock Listing

NASDAQ: TVTX

Market Capitalization $3.54 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -9.69
Forward PE 21.66
Price to Sales TTM $8.11
Price to Book MRQ $48.08
Enterprise to Revenue 8.02
Enterprise to EBITDA -99.73

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -20.32%
Operating Margin 15.12%
Return on Assets TTM -10.75%
Return on Equity TTM -410.78%

Income Statement

Revenue TTM $435,825,984
Revenue per Share TTM $4.99
Quarterly Revenue Growth 162.10%
Gross Profit TTM $215,279,008
EBITDA $-35,033,000
Net Income to Common TTM $-88,543,000
Diluted EPS TTM $-1.03
Quarterly Earnings Growth YoY 162.11%

Balance Sheet

Total Cash MRQ $254,530,000
Total Cash per Share MRQ $2.85
Total Debt MRQ $
Total Debt to Equity MRQ 448.25
Current Ratio MRQ 2.75
Book Value per Share MRQ $0.82

Cash Flow

Operating Cash Flow TTM $-58,614,000
Levered Free Cash Flow TTM $-69,019,376

TVTX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 89,456,626
Float Shares 77,306,775
Avg 10 Volume 1,883,907
Avg 30 Volume None
Shares Short 12,196,281
Short Ratio 8.48
Short % of Shares 13.73%
% Held by Insiders 0.74%
% Held by Institutions 117.80%

Stock Price Summary

Beta 0.89
Fifty Two Week Low $12.91
Fifty Two Week High $42.13
Fifty Two Week Change 52.66%
Day 50 MA $34.33
Day 200 MA $22.57

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date